Decoy Therapeutics Inc.
DCOY
$2.99
$0.010.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.45M | -13.03M | -12.52M | -5.00M | -5.10M |
| Total Depreciation and Amortization | 24.40K | 11.90K | 7.10K | 4.40K | 4.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.09M | 8.91M | 8.73M | 130.50K | 167.70K |
| Change in Net Operating Assets | -2.99M | -2.42M | -1.05M | 436.60K | 788.10K |
| Cash from Operations | -8.32M | -6.53M | -4.83M | -4.43M | -4.14M |
| Capital Expenditure | -42.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 764.70K | 764.70K | 764.70K | -200.00K | -- |
| Cash from Investing | 722.30K | 764.70K | 764.70K | -200.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -112.20K | -221.80K | -328.80K | -398.70K |
| Issuance of Common Stock | 15.10M | 11.93M | 12.59M | 6.52M | 2.09M |
| Repurchase of Common Stock | -- | -29.00K | -29.00K | -29.00K | -29.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.10M | 11.79M | 12.34M | 6.16M | 1.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.49M | 6.02M | 8.28M | 1.53M | -2.48M |